Adefovir: all 63 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive LiverCompletedNCT01146808Phase 1/2Results posted
• A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis BCompletedNCT00922207Phase 4Results posted
• Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)PatientsCompletedNCT00441974Phase 4Results posted
• Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant VirusCompletedNCT00410202Phase 3Results posted
• Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814CompletedNCT00403585Phase 4Results posted
• Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or CirrhosisCompletedNCT00347009Phase 4Results posted
• Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis BCompletedNCT00324961Phase 4Results posted
• Adefovir Dipivoxil In Compensated Chronic Hepatitis B PatientsCompletedNCT00316719Phase 3Results posted
• Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B InfectionCompletedNCT00096785Phase 3Results posted
• Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis BCompletedNCT00095121Phase 3Results posted
• Lamivudine and Adefovir to Treat Chronic Hepatitis BCompletedNCT00023309Phase 2Results posted
• Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and FurosemideCompletedNCT03801759Phase 1
• Drug Transporter Interaction Study PHENTRA_2015_KPUKCompletedNCT02743260Phase 4
• An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownNCT02560649Phase 4
• Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownNCT02327689Phase 4
• Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01829685Phase 4
• Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
• Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled TrialStatus unknownNCT01799486Phase 4
• A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male SubjectsCompletedNCT01581242Phase 1
• Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)CompletedNCT01546116Phase 4
• A Two-year Study of Telbivudine in HBeAg Negative HepatitisCompletedNCT01521975Phase 4
• Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B PatientsStatus unknownNCT01436539Phase 4
• Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01341743Phase 4
• A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedNCT01264133Phase 4
• A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedNCT01263002Phase 4
• Entecavir Plus Adefovir in Lamivudine-Resistant PatientsWithdrawnNCT00986778Phase 4
• Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNCT00973219Not applicable
• TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)Status unknownNCT00960518Phase 2
• Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV InfectionStatus unknownNCT00810524Phase 4
• ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedNCT00661076Phase 3
• Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBVCompletedNCT00645294Phase 1/2
• PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant PatientsCompletedNCT00644761Phase 2
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496158Phase 3
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496002Phase 3
• A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic ChemotherapyStatus unknownNCT00489151Not applicable
• Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
• Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedNCT00307242Phase 4
• Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALTCompletedNCT00230477Phase 4
• Effect of Age on the Renal Clearance of AdefovirWithdrawnNCT00187746Phase 4
• Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.TerminatedNCT00158704Not applicable
• Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
• Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)WithdrawnNCT00051077Phase 2
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedNCT00033163Phase 2
• Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
• Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected PatientsCompletedNCT00013702Phase 2
• A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive PatientsCompletedNCT00002426Not applicable
• Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor TreatmentCompletedNCT00002419Phase 2
• Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug CombinationsCompletedNCT00002398Not applicable
• The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsCompletedNCT00002379Phase 2
• The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected PatientsCompletedNCT00002346Phase 1
• The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected PatientsCompletedNCT00002326Phase 1
• Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected PatientsCompletedNCT00002234Phase 2
• Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With NelfinavirCompletedNCT00002220Phase 3
• Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected ChildrenStatus unknownNCT00002219Phase 2
• A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV DrugsCompletedNCT00002206Phase 1
• A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected PatientCompletedNCT00002184Phase 2
• A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3CompletedNCT00002161Not applicable
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected PatientsCompletedNCT00002128Phase 1
• A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.CompletedNCT00002115Phase 1
• The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected PatientsCompletedNCT00001082Phase 3
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000912Phase 2
• A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNCT00000892Not applicable
• The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected ChildrenCompletedNCT00000843Phase 1

← Adefovir overview